BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 28983895)

  • 1. LncRNA GHET1 promotes esophageal squamous cell carcinoma cells proliferation and invasion via induction of EMT.
    Liu H; Zhen Q; Fan Y
    Int J Biol Markers; 2017 Oct; 32(4):e403-e408. PubMed ID: 28983895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA, tissue differentiation-inducing nonprotein coding RNA is upregulated and promotes development of esophageal squamous cell carcinoma.
    Xu Y; Qiu M; Chen Y; Wang J; Xia W; Mao Q; Yang L; Li M; Jiang F; Xu L; Yin R
    Dis Esophagus; 2016 Nov; 29(8):950-958. PubMed ID: 26833746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
    Song R; Zhang J; Huang J; Hai T
    Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial-mesenchymal transition.
    Zhang CY; Li RK; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
    Cell Biol Toxicol; 2016 Oct; 32(5):391-401. PubMed ID: 27250657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis.
    Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K
    Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA RP11-766N7.4 functions as a tumor suppressor by regulating epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Yao GL; Pan CF; Xu H; Wei K; Liu B; Zhai R; Chen YJ
    Biomed Pharmacother; 2017 Apr; 88():778-785. PubMed ID: 28157654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating Notch signaling pathway in esophageal squamous cell cancer.
    Zhang Y; Jin X; Wang Z; Zhang X; Liu S; Liu G
    Cancer Biomark; 2017 Dec; 21(1):89-96. PubMed ID: 29081407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA SPRY4-IT1 promotes esophageal squamous cell carcinoma cell proliferation, invasion, and epithelial-mesenchymal transition.
    Cui F; Wu D; He X; Wang W; Xi J; Wang M
    Tumour Biol; 2016 Aug; 37(8):10871-6. PubMed ID: 26883252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulated miR-548k promotes esophageal squamous cell carcinoma progression via targeting long noncoding RNA-LET.
    Chen Z; Lin J; Wu S; Xu C; Chen F; Huang Z
    Exp Cell Res; 2018 Jan; 362(1):90-101. PubMed ID: 29126868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA-Low Expression in Tumor inhibits the invasion and metastasis of esophageal squamous cell carcinoma by regulating p53 expression.
    Wang PL; Liu B; Xia Y; Pan CF; Ma T; Chen YJ
    Mol Med Rep; 2016 Apr; 13(4):3074-82. PubMed ID: 26935396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
    Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P
    Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
    Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
    Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non‑coding RNA DLX6‑AS1 is associated with malignant progression and promotes proliferation and invasion in esophageal squamous cell carcinoma.
    Wang M; Li Y; Yang Y; Liu X; Zang M; Li Y; Yang K; Yang W; Zhang S
    Mol Med Rep; 2019 Mar; 19(3):1942-1950. PubMed ID: 30592268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma.
    Shi WH; Wu QQ; Li SQ; Yang TX; Liu ZH; Tong YS; Tuo L; Wang S; Cao XF
    Tumour Biol; 2015 Apr; 36(4):2501-7. PubMed ID: 25731728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
    Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
    Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
    J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of long noncoding RNA HOTTIP promotes metastasis of esophageal squamous cell carcinoma via induction of EMT.
    Chen X; Han H; Li Y; Zhang Q; Mo K; Chen S
    Oncotarget; 2016 Dec; 7(51):84480-84485. PubMed ID: 27806322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA LSINCT5 is upregulated and promotes the progression of esophageal squamous cell carcinoma.
    Jing L; Lin J; Zhao Y; Liu GJ; Liu YB; Feng L; Yang HY; Cui WX; Zhang XH
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5195-5205. PubMed ID: 31298370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.